One of the benefits of these medicines over older ones, like sulfonylureas or meglitinides, is that they are less likely to cause low blood sugar levels
Incretin-based medicines often raise questions about nausea, vomiting, diarrhea, constipation, abdominal discomfort, dehydration, and appetite suppression
BPC-157, short forBody Protection Compound 157, is a synthetic pentadecapeptide composed of 15 amino acids
Neyrinck In the present paper, we summarise the data supporting the following hypothesis: dietary inulin-type fructans extracted from chicory root may modulate the production of peptides, such as incretins, by endocrine cells present in the intestinal mucosa, this phenomenon being involved in the regulation of food intake and/or systemic effects
409 Trastuzumab emtansine (T-DM1) is the first approved ADC for advanced HER2+ breast cancer